Skip to main content
OpenTrials
Completed

NCT Number: NCT04746053

Ovarian Function and Gynecological Profile of Patients Carrying a Pathogenic Variant of the HNF1B Gene (GYN-HNF1)

The main objective of this study is to study the ovarian function of patients with hepatocyte nuclear factor-1beta (HNF1B) abnormality, followed in the reference centers of Toulouse and Paris University Hospitals. The secondary objectives are to know the gynecological profile of these patients.

A dosage of anti-mullerian hormone (AMH) will be added to the usual balance, whatever the phase of the cycle and a pelvic ultrasound will be performed by the same operator by center. Patients will be received in a dedicated consultation to complete a questionnaire on gynecological and obstetric history, as well as their personal and family history. There will be no gynecological examination during this consultation.

Completed

Looking for future studies?

Notify Me

Key information

Age range

12 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Necker Hospital, Paris, France

Loading trial locations.

About this study

HNF1B mutations can be responsible for genital malformations associated with renal development abnormalities. HNF1b is also a candidate gene involved in the development of the renal tract and the Mullerian system but there is no data in the literature regarding the ovarian function and clinical gynecological profile of these patients.

The main objective of this study is to study the ovarian function of patients with HNF1B abnormality, followed in the reference centers of Toulouse and Paris University Hospitals. The secondary objectives are to know the gynecological profile of these patients.

A dosage of AMH will be added to the usual balance, whatever the phase of the cycle and a pelvic ultrasound will be performed. Patients will be received in a dedicated consultation to complete a questionnaire on gynecological and obstetric history, as well as their personal and family history. There will be no gynecological examination during this consultation.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Girls from 12 years of age carrying a pathogenic variant of the HNF1 B gene and monitored in the reference center for rare renal diseases
  • Person affiliated or beneficiary of a social security scheme.
  • Free, informed and written consent signed by the participant or her legal representative if a minor patient and the investigator (at the latest on the day of inclusion and before any examination required by the research).

Exclusion criteria

  • Woman unable to answer
  • Pregnant or breastfeeding woman
  • Refusal of participation by the patient or her legal representative
  • Person under a protection system for adults (such as safeguard of justice, guardianship or curatorship)
  • History of chemotherapy, radiotherapy, brachytherapy
  • History of ovarian endometrium

Treatment and study plan

Pelvic ultrasound

Other

Pelvic or vaginal ultrasound

Blood sample

Biological

blood sample (5ml)

Primary outcomes

  1. serum level of Antimullerian Hormone levels

    Time frame: day 1

    serum level of antimullerian hormone levels in ng/mL

Secondary outcomes

  1. ultrasound result

    Time frame: day 1

    ultrasound (pelvic or vaginal) will allow the team to look at whether or not there is a genital defect and the type of defect.

Sponsors and collaborators

Lead sponsor

University Hospital, Toulouse

Other

Registry information

Official study title

Study of Ovarian Function and Gynecological Profile of Patients Carrying a Pathogenic Variant of the HNF1B Gene (GYN-HNF1)

Acronym: GYN-HNF1

Important dates

Study start
2021
Primary completion
2023
Study completion
2023
First posted
Feb 9, 2021
Registry last updated
Feb 15, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.